Skip to content

LONA LONA Increase Decrease In Accrued Legal Settlement

Increase Decrease In Accrued Legal Settlement at other companies

Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$0+100%
Mastercard logo
MastercardMA
-$461M-487%
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
-$38M+38.7%
Conagra Brands logo
Conagra BrandsCAG
-$44.5M-129%
Altria Group logo
Altria GroupMO
$659M-2.8%
Viatris logo
ViatrisVTRS
-$58M-184%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept lona:IncreaseDecreaseInAccruedLegalSettlement.

The official record: LONA’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's increase decrease in accrued legal settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's increase decrease in accrued legal settlement?
LONA (LONA) reported increase decrease in accrued legal settlement of -$2.5M in Q4 2024.
What does increase decrease in accrued legal settlement mean?
This represents the change in liabilities recognized for pending or finalized legal settlements that have been accrued but not yet paid in cash. It captures the impact of legal obligations on the company's working capital and future cash requirements. Investors use this to evaluate potential liquidity pressures arising from litigation and the timing of related cash outflows.